Latest News
Livegenic and Service Certainty Partner to Provide Leading-edge Video Collaboration Solutions
SYDNEY, Jan. 4, 2022 /PRNewswire/ -- Global insurance technology solutions
provider Wilbur (https://www.wilbur.io/
Affiliates Flock to Seal Partnerships with Malaysia Healthcare at Expo 2020 Dubai
DUBAI, UAE, Jan. 4, 2022 /PRNewswire/ -- Malaysia's healthcare travel industry led by the Malaysia Healthcare Travel Council (MHTC), welcomed more new partnerships at the Malaysia Pavilion in Expo 2020 Dubai. Memorandums of Understanding (MoUs) were exchanged with renowned players such as Interna...
ASEAN Leaders Must See Funding For Sustainability As An Investment Not A Cost, To Achieve Better Trading Opportunities
PETALING JAYA, Malaysia, Jan. 4, 2022 /PRNewswire/ -- For ASEAN to accelerate and meet the requirements by its global partners for greater sustainable trade and commerce, leaders must adopt a mega shift in behaviour and mindset. They must recognise that sustainability will require fundings and it...
Xinhua Silk Road: Chery's NEV QQ Ice Cream unveiled at a cultural festival in Wuhu, Anhui
BEIJING, Jan. 4, 2022 /PRNewswire/ -- Chery Automobile has launched its first new energy vehicle (NEV) QQ Ice Cream recently, in light of which Wuhu City of eastChina's Anhui Province held a cultural festival on December 28 to not only introduce the new auto product, but also promote Wuhu's tradi...
Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team
SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inChina, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner.Shiyu Wang will co-lead the TMT team, managing and investing in the internet and consumer sectors. Shiyu Wang has many...
CGTN: CMG president delivers New Year message to overseas audience
BEIJING, Jan. 4, 2022 /PRNewswire/ -- Shen Haixiong, president of China Media Group (CMG), extended New Year greetings in an address to overseas audiences via CGTN, China Radio International, and through the internet onJanuary 1, 2022.   CMG President Shen Haixiong said 2021 was...
Spreading the wing to enter Taiwan's robotics market to catch up with AMR trend
TAIPEI, Jan. 4, 2022 /PRNewswire/ -- All major robotic manufacturers invested a
lot to keep up with the trend of AMR. In the Automation Taipei exhibition, many
players have launched their flagship AMR products that drew people's attention.
Prudential Singapore boosts support for SMEs in their digitalisation efforts and business growth
SINGAPORE, Jan. 4, 2022 /PRNewswire/ -- Prudential Singapore ("Prudential")
has partnered Ngee Ann Polytechnic ("Ngee Ann Poly") and ST Engineering to
equip small and medium-sized enterprises (SMEs) with the knowledge and
resources on how to go digital in a safe and secure manner.
Gaw NP Industrial opens second ready-built-factory as demand soars in Vietnam
THAI NGUYEN, Vietnam, Jan. 4, 2022 /PRNewswire/ -- Gaw NP Industrial (GNP)
broke ground onDecember 28, 2021 for its second premium ready-built-factory
(RBF) project, the GNP Yen Binh 2 - Industrial Center.
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002
SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Joint research results from Biologics of Jemincare and Shanghai Institute ofMateria Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002, an anti-SARS-CoV-2 neutralizing antibody (NAb) discovered by Biologics of Jemincare is still effect...
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER
HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Today, Akeso (09926.HK) announces that Cadonilimab (PD-1/ CTLA-4 bi-specific antibody), the first-inclass novel immuno-oncology drug independently developed by the Company, combined with concurrent chemoradiotherapy obtained approval from the Center for Dru...
TCI's Golden Formula Has Won the Best Plant-Based Functional Product in the World Plant-Based Awards 2021
TAIPEI, Jan. 3, 2022 /PRNewswire/ -- In recent years, there has been a global trend of plant-based health care, which is known as vegetarian food in Taiwan. In the World Plant-Based Awards, jointly organized by FoodBev Media and Plant Based World Expo & Conference, TCI's Golden Formula won the be...
SK Group strengthens its commitment to Malaysia with over $700m investments including Digital Bank and EV
KUALA LUMPUR, Malaysia, Jan. 4, 2022 /PRNewswire/ -- SK Group, the second largest conglomerate in Korea with a market capitalization of$177bn, has committed over$700m investments in Malaysia in 2021, and intends to invest further into the country moving forward. In January 2021, SK Nexilis annou...
Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH
* ASC43F was safe and well tolerated in healthy subjects with no clinically significant study drug related adverse events * Pharmacokinetic parameters of ASC41 and ASC42 from ASC43F are similar to those of ASC41 and ASC42 monotherapy * Phase I trial completed two months after the U.S. IND ap...
Mirae Asset Scores Four Gongs at Bloomberg Businessweek's Top Fund Awards
HONG KONG, Jan. 4, 2022 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited (the "firm" or "Mirae Asset") today announced that its ETF and mutual fund products won four coveted prizes at Bloomberg Businessweek's (Chinese Edition) Top Fund Awards onDecember 10, 2021. The Global ...
Asieris Announces the World's First Patient Dose Administered in Combination of Asieris'APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients
SHANGHAI, Jan. 3, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors, today announced that the world's first patient dose has been administered in U.S. for its oral APL-1202 in combination ...
Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer
SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Everest Medicines
Buybacks of series B shares in AB Electrolux during week 52, 2021
STOCKHOLM, Jan. 4, 2022 /PRNewswire/ -- During the period December 27 – December 30, 2021 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize...
Saudi Conventions and Exhibitions General Authority officially announces Autoville motoring festival in Riyadh
- The Saudi International Festival of Motoring (Autoville) is the first and the largest interactive event of its kind in the region, bringing together more than 100 international brands in the automotive and accessories sector - Extending over an area of 1.7 million square meters, the festival is...
Acer Unveils Trio of Chromebooks for Families, Students, and Hybrid Workers
Editor's Summary * The Acer Chromebook Spin 513 (CP513-2H) boosts productivity on-the-go with a sleek, convertible design, 13.5-inch VertiView® display with a 3:2 aspect ratio, long battery life and exceptional performance—powered by the octa-core MediaTek Kompanio 1380 processor * The Acer ...
Week's Top Stories
Most Reposted
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12Klook launches K.ai, an AI agent that manages merchants' back-office operations
[Picked up by 291 media titles]
2026-11-03 14:31Arrowpoint Investment Partners Selects Arcesium to Scale Asia-Focused Multi-Strategy Platform
[Picked up by 280 media titles]
2026-11-03 09:00OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 277 media titles]
2026-10-28 09:00